Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading provider of scalable and accessible single-cell sequencing solutions today announced the launch of the ...
Single-cell science is rapidly evolving beyond "one-shot" compartment chemistry. Atrandi's SPC technology was built for ...
ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...
Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone formation in the spine, leading to severe neurological symptoms due to spinal ...
The integration of single-cell and spatial transcriptomics with advanced metabolic profiling tools has revolutionized the ...
Phyx, a universal platform for selective sample enrichment, named finalist for the SLAS2026 New Product Award Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today ...
AZoLifeSciences on MSN
SeekGene joins Human Cell Atlas Consortium to advance multiomics research
SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) ...
Dissociating tissues into single cells is a core laboratory technique and vital for widely used applications such as next-generation sequencing or flow cytometry. Scientists who employ tissue ...
Outcomes of young-onset colorectal cancer vs late-onset colorectal cancer patients on phase 1 matched and non-matched therapies. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results